GnRH-agonist-triggered frozen–thawed cycles showed comparable clinical pregnancy outcomes to those of hCG-triggered cycles, with a potentially lower OHSS risk. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.